Current Principles in the Management of Drug-Resistant Epilepsy Nathan A. ShlobinJosemir W. Sander Current Opinion 20 May 2022 Pages: 555 - 568
Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis Per Soelberg Sorensen Review Article 19 May 2022 Pages: 569 - 589
CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment William HongIsabel HavilandHeather E. Olson Review Article 28 May 2022 Pages: 591 - 604
Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain Madeline M. CorraoLeigh Anne Nelson Review Article 30 May 2022 Pages: 605 - 616
Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation Flaminia ColuzziLaura RulloPatrizia Romualdi Review Article Open access 26 May 2022 Pages: 617 - 632
Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications Yves DauvilliersKarel Ĺ onkaMichael J. Thorpy Original Research Article Open access 30 May 2022 Pages: 633 - 647
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant Lysbeth FlodenStacie HudgensJaskaran Singh Original Research Article Open access 20 April 2022 Pages: 649 - 658